Multimodal cardiometabolic risk prediction AI framework (aiMCard)

Technology
In development
University
Scouted & summarized by Halo AI

aiMCard is a multimodal artificial intelligence framework designed for integrated cardiometabolic risk prediction. Tailored for the Qatari population, the tool synthesizes clinical, biochemical, genetic, multi-omic, and imaging data to improve disease risk stratification and enable earlier, more personalized preventative healthcare interventions. The project is an active applied research initiative supported by the Qatar Research, Development, and Innovation (QRDI) Council.

Overview

The Multimodal cardiometabolic risk prediction AI framework (aiMCard) is an applied research initiative focused on creating advanced diagnostic tools for cardiometabolic diseases, including cardiovascular disease and type 2 diabetes. Developed to address the specific needs of the Qatari population, the project aims to overcome limitations in existing risk stratification methods that are primarily based on European data. By integrating a diverse range of health information, the framework seeks to provide more accurate, personalized risk assessments to enable earlier and more effective prevention strategies in clinical practice.

Technical specifications

The aiMCard framework is designed to synthesize heterogeneous medical data to generate comprehensive risk predictions. Key capabilities and data inputs include:

  • Integration of clinical and biochemical data with electronic health records.
  • Utilization of multi-omics data, including transcriptomics and proteomics.
  • Incorporation of imaging-derived measures, such as ECG, MRI, and iDXA (body fat analysis).
  • Analysis of lifestyle factors and enriched polygenic risk scores.
  • Calibration using large-scale external biobanks, such as the UK Biobank, to ensure model transferability and precision across diverse ancestral groups.
Technology readiness level

The project is currently in the active research and development phase (TRL 4), supported by the Qatar Research, Development, and Innovation (QRDI) Council and the Qatar Precision Health Institute. It is classified as an applied research project with active funding through March 2029, involving collaborative validation across clinical and biobank cohorts.

Generated Nov 17, 2026. Please verify key information.

About Hamad Bin Khalifa University

Hamad Bin Khalifa University is a private, research-intensive university in Doha and a member of Qatar Foundation, with six colleges and three national research institutes forming a multidisciplinary, impact-oriented academic model. Located in Education City, it operates within a concentrated ecosystem that places universities, research organizations, healthcare institutions, and innovation partners in close proximity. Shared core laboratories, research computing, sponsored-research support, and an expertise directory help external organizations identify capabilities and structure collaborations. Research is supported primarily by the Qatar National Research Fund, alongside competitive international and government funding. Its Office of Innovation and Industrial Relations supports industry engagement, intellectual property, technology transfer, innovation funding, and startup formation.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.